CI Investments Inc
MRNS

CI Investments Inc’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

CI Investments Inc’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,500
Closed -$17K – 1410
2022
Q3 		$17K Hold
2,500
– – ﹤0.01% 1068
2022
Q2 		$12K Hold
2,500
– – ﹤0.01% 1032
2022
Q1 		$23K Hold
2,500
– – ﹤0.01% 1044
2021
Q4 		$30K Buy
2,500
+1,300
+108% +$15K ﹤0.01% 1065
2021
Q3 		$14K Buy
+1,200
New +$16.5K ﹤0.01% 1047

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

CI Investments Inc's MRNS Position: Q4 2022 in Review

CI Investments Inc sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2022, closing a stake of 2,500 shares — an estimated $17K sold.

CI Investments Inc first reported a position in MRNS in Q3 2021 and held it in 5 quarters. The position peaked at $30K in Q4 2021. 74 funds tracked by Wall St. Rank hold MRNS as of Q4 2022.

  • CI Investments Inc reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2022 after selling out during the quarter.
  • CI Investments Inc sold 2,500 Marinus Pharmaceuticals, Inc shares in Q4 2022, an estimated $17K.
  • CI Investments Inc first reported a position in Marinus Pharmaceuticals, Inc in Q3 2021 and held it in 5 quarters.
  • CI Investments Inc's Marinus Pharmaceuticals, Inc position peaked at $30K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2022.

Based on CI Investments Inc's 13F filing for Q4 2022, filed 10 Feb 2023.